TAVR

La clave para tratar strokes: saber cuando detenerse

Should We Treat Stroke Percutaneously in TAVR?

Since its inception, transcatheter aortic valve replacement (TAVR) has improved greatly. However, there still are five big challenges to be solved: paravalvular leak, conduction disturbances, debilitating stroke, impaired kidney function, and major vascular complications and bleeding. Most cases of stroke are periprocedural and ischemic. So far, they have not been well analyzed in terms of<a href="https://solaci.org/en/2022/09/14/should-we-treat-stroke-percutaneously-in-tavr/" title="Read more" >...</a>

Es viable el alta al otro día en pacientes que reciben TAVI

Can We Discharge TAVR Patients the Same Day?

For over a decade, TAVR has been showing great benefits, but conduction abnormalities such as RBBB and prior A-V block, continue to be one of the biggest challenges, since in different series the need for definite pacemaker implantation (PPM) varies between 17 to 30% in the large, randomized studies of self-expanding valves.&nbsp;&nbsp; Even though we<a href="https://solaci.org/en/2022/09/14/can-we-discharge-tavr-patients-the-same-day/" title="Read more" >...</a>

¿Son las válvulas autoexpandibles una opción válida en las bicúspides?

TAVR in Bicuspid Patients: Are Outcomes the Same in Men and Women?

Bicuspid aortic valve stenosis (BAV) has not yet been analyzed in large, randomized studies, and TAVR in this scenario has been assessed only by small fairly studies. However, the information available is quite promising.&nbsp;&nbsp; TAVR in women generally presents more complications than in men, but severe bicuspid aortic valve stenosis receiving TAVR has not been<a href="https://solaci.org/en/2022/08/26/tavr-in-bicuspid-patients-are-outcomes-the-same-in-men-and-women/" title="Read more" >...</a>

Post-dilatación de válvulas autoexpandibles

Balloon expandable vs Self-Expanding Valves: The Best Option for ViV-TAVR in Small Annuli

TAVR has consolidated as an increasingly valid alternative to treat failed surgical aortic valve bioprostheses. &nbsp; One of the major challenges it presents is patients with small annuli treated with a surgical bioprosthesis.&nbsp; There is little data available about this scenario. A few observational studies have shown what appears to be a hemodynamic advantage of<a href="https://solaci.org/en/2022/08/23/balloon-expandable-vs-self-expanding-valves-the-best-option-for-viv-tavr-in-small-annuli/" title="Read more" >...</a>

Stroke criptogénico y el fin de la controversia sobre el cierre del foramen oval

Combination of Percutaneous Suture Devices after TAVR to Reduce Vascular Complications

Current use of transcatheter aortic valve replacement (TAVR) has increased in intermediate-risk patients and has even been used in low-risk patients. Vascular access-related complications and bleeding are still frequent after transfemoral TAVR, being associated with poor short- and long-term outcomes. Using percutaneous closure devices has allowed operators to close the access site without surgery. The<a href="https://solaci.org/en/2022/08/16/combination-of-percutaneous-suture-devices-after-tavr-to-reduce-vascular-complications/" title="Read more" >...</a>

tavi vs cirugia partner i

Non-Cardiac Surgery After TAVR Is Safe

There are increasingly more patients who have undergone transcatheter aortic valve replacement (TAVR) and require a non-cardiac intervention, or patients with other diseases who need surgery and are diagnosed with aortic stenosis.&nbsp; In addition, on many occasions, surgery must be performed as soon as possible (as in cases of cancer) or is an emergency procedure.<a href="https://solaci.org/en/2022/08/11/non-cardiac-surgery-after-tavr-is-safe/" title="Read more" >...</a>

The Best of Main Arena - SOLACI-SOCIME 2022

The Best of the SOLACI-SOCIME 2022 Main Arena: Structural—Selected Topics of TAVR

On the last session from day 1 of SOLACI-SOCIME 2022 on structural pathology, Dr. Raj Makkar, an international expert on the subject, talked about transcatheter aortic valve replacement (TAVR) in pure aortic regurgitation (AR), which presents several implantation challenges, such as insufficient anchoring, embolization, residual regurgitation, ring rupture, etc.&nbsp; As opposed to patients with aortic<a href="https://solaci.org/en/2022/08/09/the-best-of-the-solaci-socime-2022-main-arena-structural-selected-topics-of-tavr/" title="Read more" >...</a>

The Best of Main Arena - SOLACI-SOCIME 2022

The Best of the Main Arena at SOLACI-SOCIME 2022: TAVR Complex Anatomy

In the transcatheter aortic valve replacement (TAVR) session we had a presentation by Dr. John P. Vavalle (USA), head of the Structural Heart Disease Program at the University of North Carolina at Chapel Hill.&nbsp; In his presentation, he showed how far the limits of percutaneous aortic valve implantation can be stretched by briefly showing successful<a href="https://solaci.org/en/2022/08/09/the-best-of-the-main-arena-at-solaci-socime-2022-tavr-complex-anatomy/" title="Read more" >...</a>

El Grupo MIL realizó 4 TAVIS en Paraguay

The Latin American Group of Interventionist Women Performed 4 TAVR Cases in Paraguay

The MIL-SOLACI continues to grow and keeps developing activities to foster integration and women’s participation all across Latin America.&nbsp; IN this opportunity, and for the first time, the area directed by Dr. Carla Agatiello (ARG) performed 4 transcatheter aortic valve implantations (TAVR) at the National University’s Clinical Hospital of Asunción, in Paraguay.&nbsp; The interventions, performed<a href="https://solaci.org/en/2022/06/30/the-latin-american-group-of-interventionist-women-performed-3-tavr-cases-in-paraguay/" title="Read more" >...</a>

Top